Tripeptide motifs in biology: Targets for peptidomimetic design

Journal of Medicinal Chemistry

Volumn 54, Issue 5, 2011, Pages 1111-1125

  Ung, Phuc ^a,b   Winkler, David A ^a,b  

^a CSIRO   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALPHA INTERMEDIN; ALPHA4 INTEGRIN ANTAGONIST; ANTINEOPLASTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; BIPHENYLALANINE; CADHERIN; DISINTEGRIN; DOPAMINE RECEPTOR AFFECTING AGENT; EPTIFIBATIDE; GLUTAMYLLEUCYLARGININE; GLUTATHIONE; GLYCYLHISTIDYLLYSINE; GLYCYLPROLYLGLUTAMATE; HISTIDYLALANYLVALINE; HISTIDYLGLYCYLLYSINE; LEUCYLASPARTYLVALINE; LYSYLPROLYLVALINE; N [N [5 [4 (AMINOIMINOMETHYL)PHENYL]PENTANOYL]ASPARTYL]PHENYLALANINE; NEUROPROTECTIVE AGENT; PEPTIDOMIMETIC AGENT; POSATIRELIN; PROTEIN INHIBITOR; PROTIRELIN; REPARIXIN; TALTIRELIN; TECHNETIUM 99M; TIROFIBAN; TRIPEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO TERMINAL SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; COGNITIVE DEFECT; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG TARGETING; FUNCTIONAL DISEASE; HUMAN; INFECTION; INFLAMMATION; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; SPINAL MUSCULAR ATROPHY; STOP CODON; STRUCTURE ACTIVITY RELATION; THROMBOSIS; TISSUE REGENERATION; WOUND HEALING;

AMINO ACID MOTIFS; ANIMALS; CONSERVED SEQUENCE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MOLECULAR TARGETED THERAPY; OLIGOPEPTIDES; PEPTIDOMIMETICS; SIGNAL TRANSDUCTION;

EID: 79952270364     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm1012984     Document Type: Article

References (159)

1. Reynolds, C. H.; Bembenek, S. D.; Tounge, B. A. The role of molecular size in ligand efficiency Bioorg. Med. Chem. Lett. 2007, 17, 4258-4261 (Pubitemid 47028600)
2. Neduva, V.; Russell, R. B. DILIMOT: discovery of linear motifs in proteins Nucleic Acids Res. 2006, 34, W350-W355
3. Hann, M. M.; Leach, A. R.; Harper, G. Molecular complexity and its impact on the probability of finding leads for drug discovery J. Chem. Inf. Comput. Sci. 2001, 41, 856-864
4. Leach, A. R.; Bradshaw, J.; Green, D. V. S.; Hann, M. M.; Delany, J. J. Implementation of a system for reagent selection and library enumeration, profiling, and design J. Chem. Inf. Comput. Sci. 1999, 39, 1161-1172 (Pubitemid 129579852)
5. Anishetty, S.; Anishetty, R.; Pennathur, G. Understanding mutations and protein stability through tripeptides FEBS Lett. 2006, 580, 2071-2080
6. Anishetty, S.; Pennathur, G. Distribution of tripeptides in MHC binding peptides Protein Pept. Lett. 2007, 14, 552-556 (Pubitemid 47041572)
7. Anishetty, S.; Pennathur, G.; Anishetty, R. Tripeptide analysis of protein structures BMC Struct. Biol. 2002, 2, 9
8. Brooks, D. J.; Fresco, J. R.; Lesk, A. M.; Singh, M. Evolution of amino acid frequencies in proteins over deep time: inferred order of introduction of amino acids into the genetic code Mol. Biol. Evol. 2002, 19, 1645-1655
9. Gatto, G. J.; Berg, J. M. Nonrandom tripeptide sequence distributions at protein carboxyl termini Genome Res. 2003, 13, 617-623 (Pubitemid 36511920)
10. Otaki, J. M.; Gotoh, T.; Yamamoto, H. Potential implications of availability of short amino acid sequences in proteins: an old and new approach to protein decoding and design Biotechnol. Annu. Rev. 2008, 14, 109-41 (Pubitemid 351903451)
11. Shiba, K. Natural and artificial peptide motifs: their origins and the application of motif-programming Chem. Soc. Rev. 2010, 39, 117-126
12. Meyer, A.; Auernheimer, J.; Modlinger, A.; Kessler, H.; Targeting, R. G. D. Recognizing integrins: drug development, biomaterial research, tumor imaging and targeting Curr. Pharm. Des. 2006, 12, 2723-2747 (Pubitemid 44184633)
13. Aoyama, K.; Watabe, M.; Nakaki, T. Regulation of neuronal glutathione synthesis J. Pharmacol. Sci. 2008, 108, 227-238
14. Dringen, R. Metabolism and functions of glutathione in brain Prog. Neurobiol. 2000, 62, 649-671 (Pubitemid 30407139)
15. Jain, A.; Martensson, J.; Stole, E.; Auld, P. A.; Meister, A. Glutathione deficiency leads to mitochondrial damage in brain Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 1913-1917 (Pubitemid 21916337)
16. Zeevalk, G. D.; Manzino, L.; Sonsalla, P. K.; Bernard, L. P. Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease Exp. Neurol. 2007, 203, 512-520 (Pubitemid 46149596)
17. Kannan, R.; Yi, J. R.; Tang, D.; Li, Y.; Zlokovic, B. V.; Kaplowitz, N. Evidence for the existence of a sodium-dependent glutathione (GSH) transporter. Expression of bovine brain capillary mRNA and size fractions in Xenopus laevis oocytes and dissociation from gamma-glutamyltranspeptidase and facilitative GSH transporters J. Biol. Chem. 1996, 271, 9754-9758
18. Cornford, E. M.; Braun, L. D.; Crane, P. D.; Oldendorf, W. H. Blood-brain barrier restriction of peptides and the low uptake of enkephalins Endocrinology 1978, 103, 1297-1303 (Pubitemid 9059227)
19. Montali, J. A.; Wheatley, J. B.; Schmidt, D. E., Jr. Comparison of GST levels in predicting the efficacy of a novel alkylating agent Cell. Pharmacol. 1996, 2, 241-247
20. Wang, R. W.; Newton, D. J.; Huskey, S. E. W.; McKeever, B. M.; Pickett, C. B.; Lu, A. Y. H. Site directed mutagenesis of glutathione S -transferase YaYa J. Biol. Chem. 1987, 267, 19866-19871
21. Morgan, A. S.; Sanderson, P. E.; Borch, R. F.; Tew, K. D.; Niitsu, Y.; Takayama, T.; Von Hoff, D. D.; Izbicka, E.; Mangold, G.; Paul, C.; Broberg, U.; Mannervik, B.; Henner, W. D.; Kauvar, L. M. Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S -transferase Cancer Res. 1998, 58, 2568-2575 (Pubitemid 28275427)
22. Sun, Y.; Lu, X.; Gershengorn, M. C. Thyrotropin-releasing hormone receptors, similarities and differences J. Mol. Endocrinol. 2003, 30, 87-89
23. Buesen, D. D.; Shands, E. F. B. Systematic search strategies in conformational analysis Drug Discovery Today 1996, 1, 429-437 (Pubitemid 126658984)
24. Dammkoehler, R. A.; Karasek, S. F.; Shands, E. F. B.; Marshall, G. R. Constrained search of conformational hyperspace J. Comput.-Aided Mol. Des. 1989, 3, 3-21
25. Dammkoehler, R. A.; Karasek, S. F.; Shands, E. F. B.; Marshall, G. R. Sampling conformational hyperspace: techniques for improving completeness J. Comput.-Aided Mol. Des. 1995, 9, 491-499
26. Tong, Y.; Olczak, J.; Zabrocki, J.; Gershengorn, M. C.; Marshall, G. R.; Moeller, K. D. Constrained peptidomimetics for TRH: cis-peptide bond analogs Tetrahedron 2000, 56, 9791-9800
27. Engel, S.; Gershengorn, M. C. Thyrotropin-releasing hormone and its receptors: a hypothesis for binding and receptor activation Pharmacol. Ther. 2007, 113, 410-419 (Pubitemid 46149053)
28. Monga, V.; Meena, C. L.; Kaur, N.; Jain, R. Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs Curr. Med. Chem. 2008, 15, 2718-2733
29. Mason, G. A.; Rezvani, A. H.; Grady, D. R.; Garbutt, J. C. The subchronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol-preferring rats: development of tolerance and cross-tolerance Alcoholism 1994, 18, 1196-1201 (Pubitemid 24345530)
30. Prokai, L. Central nervous system effects of thyrotropin-releasing hormone and its analogues: opportunities and perspectives for drug discovery and development Prog. Drug Res. 2002, 59, 134-169
31. Yamamura, M.; Kinoshita, K.; Nakagawa, H.; Tanaka, T.; Maeda, K.; Ishida, R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone(TRH) analog. (I). Effects on the central nervous system by oral administration Jpn. J. Pharmacol. 1990, 53, 451-461 (Pubitemid 20252328)
32. Parnetti, L.; Ambrosoli, L.; Abate, G.; Azzini, C.; Balestreri, R.; Bartorelli, L.; Bordin, A.; Crepaldi, G.; Cristianini, G.; Cucinotta, D.; Cuzzupoli, M.; Decandia, O.; Fabris, F.; Maggioni, M.; Scarpa, R.; Villardita, C.; Girardello, R.; Poli, A.; Senin, U. Posatirelin for the Treatment of late-onset Alzheimer's-disease: a double-blind multicenter study vs citicoline and ascorbic-acid Acta Neurol. Scand. 1995, 92, 135-140
33. Nutt, R. F.; Holly, F. W.; Homnick, C.; Hirschmann, R.; Veber, D. F.; Arison, B. H. Synthesis of thyrotropin-releasing-hormone analogs with selective central nervous-system effects J. Med. Chem. 1981, 24, 692-698 (Pubitemid 11043248)
34. Nillni, E. A.; Sevarino, K. A. The biology of pro-thyrotropin-releasing hormone-derived peptides Endocr. Rev. 1999, 20, 599-648 (Pubitemid 30650601)
35. Mathison, R.; Davison, J. S.; Moore, G. Submandibular gland peptide-T (Peptide-T): modulation of endotoxic and anaphylactic shock Drug Dev. Res. 1997, 42, 164-71 (Pubitemid 28243284)
36. Mathison, R.; Lo, P.; Moore, G.; Scott, B.; Davison, J. S. Attenuation of intestinal and cardiovascular anaphylaxis by the salivary gland tripeptide FEG and its D-isomeric analog feG Peptides 1998, 19, 1037-1042 (Pubitemid 28383800)
37. Dery, R. E.; Ulanova, M.; Puttagunta, L.; Stenton, G. R.; James, D.; Merani, S.; Mathison, R.; Davison, J.; Befus, A. D. Frontline: inhibition of allergen-induced pulmonary inflammation by the tripeptide feG: a mimetic of a neuro-endocrine pathway Eur. J. Immunol. 2004, 34, 3315-3325 (Pubitemid 40012151)
38. Turesin, F.; Sadr, A.; Davison, J. S.; Mathison, R. The tripeptide feG ameliorates systemic inflammatory responses to rat intestinal anaphylaxis BMC Physiol. 2002, 2, 13
39. Bao, F.; John, S. M.; Chen, Y.; Mathison, R. D.; Weaver, L. C. The tripeptide phenylalanine-(D) glutamate-(D) glycine modulates leukocyte infiltration and oxidative damage in rat injured spinal cord Neuroscience 2006, 140, 1011-1022 (Pubitemid 43767459)
40. Mathison, R.; Befus, A. D.; Davison, J. S.; Woodman, R. C. Modulation of neutrophil function by the tripeptide feG BMC Immunol. 2003, 4, 3
41. Mathison, R.; Woodman, R.; Davison, J. S. Regulation of leukocyte adhesion to heart by the tripeptides feG and feG(NH2) Can. J. Physiol. Pharmacol. 2001, 79, 785-792 (Pubitemid 33033446)
42. Mathison, R. D.; Davison, J. S. The tripeptide feG regulates the production of intracellular reactive oxygen species by neutrophils J. Inflammation 2006, 3, 9
43. Metwally, E.; Pires, J. M.; Moore, G. J.; Befus, D. A.; Davison, J. S.; Mathison, R. Submandibular gland tripeptide FEG (Phe-Glu-Gly) and analogues: keys to structure determination Peptides 2002, 23, 193-199 (Pubitemid 34113779)
44. Galeazzi, R.; Martelli, G.; Marcucci, E.; Mobbili, G.; Natali, D.; Orena, M.; Rinaldi, S. A new conformationally restricted mimetic of dipeptide EG synthesis of an analogue of FEG Eur. J. Org. Chem. 2007, 26, 4402-4407
45. Freedman, J. H.; Pickart, L.; Weinstein, B.; B., M. W.; Peisach, J. Structure of the glycyl- l -histidyl- l -lysine-copper(II) complex in solution Biochemistry 1982, 21, 4540-4544
46. Kwa, E.; Bor-Sheng, L.; Rose, N.; B., W.; Pickart, L. PMR studies of copper(II) and zinc(II) interaction with glycyl- l -histidyl- l -lysine and related peptides Peptides 1983, 8, 805-808
47. Lau, S. J.; Sarkar, B. The interaction of copper(II) and glycyl- l -histidyl- l -lysine, a growth-modulating tripeptide from plasma Biochem. J. 1981, 199, 649-656 (Pubitemid 12190973)
48. Laussac, J. P.; R., H.; Sarkar, B. N.m.r. and e.p.r. investigation of the interaction of copper(II) and glycyl- l -histidyl- l -lysine, a growth-modulating tripeptide from plasma Biochem. J. 1983, 209, 533-539 (Pubitemid 13163725)
49. Perkins, C. M.; Rose, N. J.; Weinstein, B.; Stenkamp, R. E.; Jensen, L. H.; Pickart, L. The structure of a copper complex of the growth factor glycyl- l -histidyl- l -lysine at 1.1 Å resolution Inorg. Chim. Acta 1984, 82, 93-99
50. Pickart, L. The human tri-peptide GHK and tissue remodeling J. Biomater. Sci., Polym. Ed. 2008, 19, 969-988 (Pubitemid 351957385)
51. Pickart, L. The human tri-peptide GHK and tissue remodeling J. Biomater. Sci., Polym. Ed. 2008, 19, 969-988 (Pubitemid 351957385)
52. Ahmed, M. R.; Basha, S. H.; Gopinath, D.; R., M.; Jayakumar, R. Initial upregulation of growth factors and inflammatory mediators during nerve regeneration in the presence of cell adhesive peptide-incorporated collagen tubes J. Peripher. Nerv. Syst. 2005, 10, 17-30 (Pubitemid 40289578)
53. Lindner, G.; Grosse, G.; W., H.; Henklein, P. The effect of a synthetic tripeptide nervous tissue cultured in vitro Z. Mikrosk. Anat. Forsch. 1979, 93, 820-828 (Pubitemid 10132727)
54. Sensenbrenner, M.; Jaros, G. G.; Moonen, G.; Mandel, P. Effects of synthetic tripeptide on the differentiation of dissociated cerebral hemisphere nerve cells in culture Neurobiology 1975, 5, 207-213
55. Kang, Y. A.; Choi, H. R.; Na, J. I.; Huh, C. H.; Kim, M. J.; Youn, S. W.; Kim, K. H.; Park, K. C. Copper-GHK increases integrin expression and p63 positivity by keratinocytes Arch. Dermatol. Res. 2009, 301, 301-306
56. Lane, T. F.; Iruelaarispe, M. L.; Johnson, R. S.; Sage, E. H. Sparc is a source of copper-binding peptides that stimulate angiogenesis J. Cell Biol. 1994, 125, 929-943 (Pubitemid 24151186)
57. 2+ in rat experimental wounds J. Clin. Invest 1993, 92, 2368-2376 (Pubitemid 23333544)
58. 2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures Life Sci. 2000, 67, 2257-2265
59. Zheng, Y. J.; Huo, Q.; Kele, P.; Andreopoulos, F. M.; Pham, S. M.; Leblanc, R. M. A new fluorescent chemosensor for copper ions based on tripeptide glycyl-histidyl-lysine (GHK) Org. Lett. 2001, 3, 3277-3280 (Pubitemid 33625340)
60. Saitton, S.; Del Tredici, A. L.; Saxin, M.; Stenstrom, T.; Kihlberg, J.; Luthman, K. Synthesis and evaluation of novel pyridine based PLG tripeptidomimetics Org. Biomol. Chem. 2008, 6, 1647-1654 (Pubitemid 351555183)
61. Mishra, R. K.; Srivastava, L. K.; Johnson, R. L. Modulation of high-affinity CNS dopamine-D2 receptor by l -Pro- l -Leu-glycinamide (Plg) analog 3(R)-(N-l -prolylamino)-2-oxo-1-pyrrolidineacetamide Prog. Neuro-Psychopharmacol. Biol. Psychiatry 1990, 14, 821-827 (Pubitemid 20347615)
62. 2O J. Am. Chem. Soc. 1973, 95, 7523-7524
63. 2 J. Med. Chem. 1993, 36, 256-263 (Pubitemid 23060094)
64. 2 J. Med. Chem. 1993, 36, 2356-2361 (Pubitemid 23262468)
65. Baures, P. W.; Pradhan, A.; Ojala, W. H.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of l -prolyl- l -leucyl-glycinamide (PLG) Bioorg. Med. Chem. Lett. 1999, 9, 2349-2352 (Pubitemid 29391520)
66. Evans, M. C.; Pradhan, A.; Venkatraman, S.; Ojala, W. H.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Synthesis and dopamine receptor modulating activity of novel peptidomimetics of l -prolyl- l -leucyl-glycinamide featuring alpha,alpha-disubstituted amino acids J. Med. Chem. 1999, 42, 1441-1447 (Pubitemid 29200880)
67. 2 modified at the leucyl residue J. Med. Chem. 1990, 33, 1828-1832 (Pubitemid 20180650)
68. 2 analogs possessing cyclic amino-acid-residues at the C-terminal position J. Med. Chem. 1986, 29, 2100-2104 (Pubitemid 16030326)
69. 2 analogs modified at the prolyl residue and evaluation of their effects on the receptor-binding activity of the central dopamine receptor agonist, ATDN J. Med. Chem. 1986, 29, 2104-2107 (Pubitemid 16030327)
70. Palomo, C.; Aizpurua, J. M.; Benito, A.; Miranda, J. I.; Fratila, R. M.; Matute, C.; Domercq, M.; Gago, F.; Martin-Santamaria, S.; Linden, A. Development of a new family of conformationally restricted peptides as potent nucleators of beta-turns. Design, synthesis, structure, and biological evaluation of beta-lactam peptide analogue of melanostatin J. Am. Chem. Soc. 2003, 125, 16243-16260 (Pubitemid 38028559)
71. Rajakumar, G.; Naas, F.; Johnson, R. I.; Chiu, S.; Yu, K. L.; Mishra, R. K. Down-regulation of halperidol-induced striatal dopamine receptor supersensitivity by active analogs of l -prolyl- l -leucyl-glycinamide (PLG) Peptides 1987, 8, 855-861
72. Thomas, C.; Ohnmacht, U.; Niger, M.; Gmeiner, P. Beta analogues of PLG (l -prolyl- l -leucyl-glycinamide): ex-chiral pool syntheses and dopamine D-2 receptor modulating effects Bioorg. Med. Chem. Lett. 1998, 8, 2885-2890 (Pubitemid 28483187)
73. Baures, P. W.; Ojala, W. H.; Costain, W. J.; Ott, M. C.; Pradhan, A.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of l -prolyl- l -leucylglycinamide J. Med. Chem. 1997, 40, 3594-3600 (Pubitemid 27465091)
74. Dolbeare, K.; Pontoriero, G. F.; Gupta, S. K.; Mishra, R. K.; Johnson, R. L. Iso-lactam and reduced amide analogues of the peptidomimetic dopamine receptor modulator 3(R)-(2(S)pyrrolidinylcarbonyl) amino-2-oxo-1- pyrrolidineacetamide Bioorg. Med. Chem. 2003, 11, 4103-4112 (Pubitemid 36970137)
75. Dolbeare, K.; Pontoriero, G. F.; Gupta, S. K.; Mishra, R. K.; Johnson, R. L. Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of l -prolyl- l -leucyl-glycinamide J. Med. Chem. 2003, 46, 727-733 (Pubitemid 36258864)
76. 2 J. Med. Chem. 1993, 36, 3481-3483 (Pubitemid 23335715)
77. Khalil, E. M.; Ojala, W. H.; Pradhan, A.; Nair, V. D.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of l -prolyl- l -leucyl-glycinamide J. Med. Chem. 1999, 42, 628-637 (Pubitemid 29110779)
78. Khalil, E. M.; Pradhan, A.; Ojala, W. H.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. Synthesis and dopamine receptor modulating activity of substituted bicyclic thiazolidine lactam peptidomimetics of l -prolyl- l -leucyl-glycinamide J. Med. Chem. 1999, 42, 2977-2987 (Pubitemid 29370442)
79. Weber, K.; Ohnmacht, U.; Gmeiner, P. Enantiopure 4-and 5-aminopiperidin-2-ones: regiocontrolled synthesis and conformational characterization as bioactive beta-turn mimetics J. Org. Chem. 2000, 65, 7406-7416
80. 2 J. Med. Chem. 1988, 31, 1430-1436
81. Genin, M. J.; Johnson, R. L. Design, synthesis, and conformational analysis of a novel spiro-bicyclic system as a type II.beta.-turn peptidomimetic J. Am. Chem. Soc. 1992, 114, 8778-8783
82. Saitton, S.; Del Tredici, A. L.; Mohell, N.; Vollinga, R. C.; Bostrom, D.; Kihlberg, J.; Luthman, K. Design, synthesis and evaluation of a PLG tripeptidomimetic based on a pyridine scaffold J. Med. Chem. 2004, 47, 6595-6602 (Pubitemid 39657320)
83. Wijffels, G.; Dalrymple, B. P.; Prosselkov, P.; Kongsuwan, K.; Epa, V. C.; Lilley, P. E.; Jergic, S.; Buchardt, J.; Brown, S. E.; Alewood, P. F.; Jennings, P. A.; Dixon, N. E. Inhibition of protein interactions with the β2 sliding clamp of Escherichia coli DNA polymerase III by peptides from beta(2)-binding proteins Biochemistry 2004, 43, 5661-5671 (Pubitemid 38623600)
84. Dalrymple, B. P.; Kongsuwan, K.; Wijffels, G.; Dixon, N. E.; Jennings, P. A. A universal protein-protein interaction motif in the eubacterial DNA replication and repair systems Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 11627-11632 (Pubitemid 32928779)
85. Alewood, P.; Briscoe, S.; Buchardt, J.; Christensen, C.; Dalrymple, B.; Dixon, N. E.; Epa, V. C.; Hofmann, A.; Jennings, P.; Oakley, A.; Polley, M.; Wijffels, G.; Winkler, D. A. Bacterial replisome β clamp inhibitors as potential broad-spectrum antimicrobials. Unpublished results.
86. Murphy, P. M.; Baggiolini, M.; Charo, I. F.; Hebert, C. A.; Horuk, R.; Matsushima, K. International union of pharmacology: XXII. Nomenclature for chemokine receptors Pharmacol. Rev. 2000, 52, 145-176 (Pubitemid 30127598)
87. Holmes, W. E.; Lee, J.; Kuang, W. J.; Rice, G. C.; Wood, W. I. Structure and functional expression of a human interleukin-8 receptor Science 1991, 253, 1278-1280 (Pubitemid 21917277)
88. Murphy, P. M.; Tiffany, H. L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor Science 1991, 253, 1280-1283 (Pubitemid 21917278)
89. Mathison, R. Modulation of neutrophil function by hormones Curr. Immunol. Rev. 2006, 2, 247-259
90. Bizzarri, C.; Beccari, A. R.; Bertini, R.; Cavicchia, M. R.; Giorgini, S.; Allegretti, M. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets Pharmacol. Ther. 2006, 112, 139-149 (Pubitemid 44314001)
91. Widdowson, K. L.; Elliott, J. D.; Veber, D. F.; Nie, H.; Rutledge, M. C.; McCleland, B. W.; Xiang, J. N.; Jurewicz, A. J.; Hertzberg, R. P.; Foley, J. J.; Griswold, D. E.; Martin, L.; Lee, J. M.; White, J. R.; Sarau, H. M. Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor J. Med. Chem. 2004, 47, 1319-1321 (Pubitemid 38327458)
92. Bertini, R.; Bizzari, C.; Sabbatini, V.; Porzio, S.; Caselli, G.; Allegretti, M. N -(2-Aryl-propionyl)-sulfonamides and Pharmaceutical Preparations Containing Them. WO 2000024710, 2000.
93. Widdowson, K. L. IL-8 Receptor Antagonist. WO 1997049286, 1997.
94. Bertini, R.; Allegretti, M.; Bizzarri, C.; Moriconi, A.; Locati, M.; Zampella, G.; Cervellera, M. N.; Di Cioccio, V.; Cesta, M. C.; Galliera, E.; Martinez, F. O.; Di Bitondo, R.; Troiani, G.; Sabbatini, V.; D'Anniballe, G.; Anacardio, R.; Cutrin, J. C.; Cavalieri, B.; Mainiero, F.; Strippoli, R.; Villa, P.; Di Girolamo, M.; Martin, F.; Gentile, M.; Santoni, A.; Corda, D.; Poli, G.; Mantovani, A.; Ghezzi, P.; Colotta, F. Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 11791-11796 (Pubitemid 39095373)
95. Batchelor, D. C.; Lin, H.; Wen, J. Y.; Keven, C.; Van Zijl, P. L.; Breier, B. H.; Gluckman, P. D.; Thomas, G. B. Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats Anal. Biochem. 2003, 323, 156-163 (Pubitemid 37491137)
96. Guan, J.; Waldvogel, H. J.; Faull, R. L.; Gluckman, P. D.; Williams, C. E. The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats Neuroscience 1999, 649-659 (Pubitemid 29070993)
97. Saura, J.; Curatolo, L.; Williams, C. E.; Gatti, S.; Benatti, L.; Peeters, C.; Guan, J.; Dragunow, M.; Post, C.; Faull, R. L.; Gluckman, P. D.; Skinner, S. J. Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro NeuroReport 1999, 10, 161-164 (Pubitemid 29090500)
98. Sizonenko, S. V.; Sirimanne, E. S.; Williams, C. E.; Gluckman, P. D. Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury Brain Res. 2001, 922, 42-50 (Pubitemid 33152843)
99. De Diego, S. A. A.; Gutierrez-Rodriguez, M.; de Vega, M. J. P.; Casabona, D.; Cativiela, C.; Gonzalez-Muniz, R.; Herranz, R.; Cenarruzabeitia, E.; Frechilla, D.; Del Rio, J.; Jimeno, M. L.; Garcia-Lopez, M. T. New Gly-Pro-Glu (GPE) analogues: expedite solid-phase synthesis and biological activity Bioorg. Med. Chem. Lett. 2006, 16, 1392-1396 (Pubitemid 43143028)
100. Alonso De Diego, S. A.; Gutierrez-Rodriguez, M.; Perez de Vega, M. J.; Gonzalez-Muniz, R.; Herranz, R.; Martin-Martinez, M.; Cenarruzabeitia, E.; Frechilla, D.; Del Rio, J.; Jimeno, M. L.; Garcia-Lopez, M. T. The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity Bioorg. Med. Chem. Lett. 2006, 16, 3396-3400 (Pubitemid 43792525)
101. Alonso DeDiego, S. A.; Munoz, P.; Gonzalez-Muniz, R.; Herranz, R.; Martin-Martinez, M.; Cenarruzabeitia, E.; D., F.; Del Rio, J.; Jimeno, M. L.; Garcia-Lopez, M. T. Analogues of the neuroprotective tripeptide Gly-Pro-Glu (GPE): synthesis and structure-activity relationships Bioorg. Med. Chem. Lett. 2005, 15, 2279-2283 (Pubitemid 40523086)
102. Brimble, M. A.; Trotter, N. S.; Harris, P. W. R.; Sieg, F. Synthesis and pharmacological evaluation of side chain modified glutamic acid analogues of the neuroprotective agent glycyl- L -prolyl- L -glutamic acid (GPE) Bioorg. Med. Chem. 2005, 13, 519-532 (Pubitemid 39642934)
103. Harris, P. W. R.; Brimble, M. A.; Muir, V. J.; Lai, M. Y. H.; S., T. N.; Callis, D. J. Synthesis of proline-modified analogues of the neuroprotective agent glycyl- L -prolyl- L -glutamic acid (GPE) Tetrahed. 2005, 61, 10018-10035 (Pubitemid 41317480)
104. Lai, M. Y. H.; Brimble, M. A.; Callis, D. J.; Harris, P. W. R.; Levi, M. S.; Sieg, F. Synthesis and pharmacological evaluation of glycine-modified analogues of the neuroprotective agent glycyl- L -prolyl- L -glutamic acid (GPE) Bioorg. Med. Chem. 2005, 13, 533-548 (Pubitemid 39642935)
105. Trotter, N. S.; Brimble, M. A.; Harris, P. W.; Callis, D. J.; Sieg, F. Synthesis and neuroprotective activity of analogues of glycyl- L -prolyl- L -glutamic acid (GPE) modified at the α-carboxylic acid Bioorg. Med. Chem. 2005, 13, 501-517 (Pubitemid 39642933)
106. Kisselev, L.; Ehrenberg, M.; Frolova, L. Termination of translation: interplay of mRNA, rRNAs and release factors? EMBO J. 2003, 22, 175-182 (Pubitemid 36119423)
107. Frolova, L. Y.; Tsivkovskii, R. Y.; Sivolobova, G. F.; Oparina, N. Y.; Serpinsky, O. I.; Blinov, V. M.; Tatkov, S. I.; Kisselev, L. L. Mutations in the highly conserved GGQ motif of class 1 polypeptide release factors abolish ability of human eRF1 to trigger peptidyl-tRNA hydrolysis RNA 1999, 5, 1014-1020 (Pubitemid 29365331)
108. Williams, G.; Williams, E. J.; Doherty, P. Dimeric versions of two short N-cadherin binding motifs (HAVDI and INPISG) function as N-cadherin agonists J. Biol. Chem. 2002, 277, 4361-4367 (Pubitemid 34968702)
109. Williams, E. J.; Furness, J.; Walsh, F. S.; Doherty, P. Activation of the Fgf receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin Neuron 1994, 13, 583-594 (Pubitemid 24300164)
110. Halbleib, J. M.; Nelson, W. J. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis Genes Dev. 2006, 20, 3199-3214 (Pubitemid 44904842)
111. Gumbiner, B. M. Regulation of cadherin-mediated adhesion in morphogenesis Nat. Rev. Mol. Cell Biol. 2005, 6, 622-634 (Pubitemid 41081266)
112. Pokutta, S.; Weis, W. I. Structure and mechanism of cadherins and catenins in cell-cell contacts Annu. Rev. Cell Dev. Biol. 2007, 23, 237-261
113. Blaschuk, O. W.; Sullivan, R.; David, S.; Pouliot, Y. Identification of a cadherin cell-adhesion recognition sequence Dev. Biol. 1990, 139, 227-229
114. Williams, E. J.; Williams, G.; Gour, B.; Blaschuk, O.; Doherty, P. INP, a novel N-cadherin antagonist targeted to the amino acids that flank the HAV motif Mol. Cell. Neurosci. 2000, 15, 456-464 (Pubitemid 30395370)
115. Williams, E.; Williams, G.; Gour, B. J.; Blaschuk, O. W.; Doherty, P. A novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined by amino acids that flank the HAV motif J. Biol. Chem. 2000, 275, 4007-4012 (Pubitemid 30094629)
116. Makagiansar, I. T.; Avery, M.; Hu, Y.; Audus, K. L.; Siahaan, T. J. Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers Pharm. Res. 2001, 18, 446-453 (Pubitemid 32592575)
117. Lutz, K. L.; Jois, S. D. S.; Siahaan, T. J. Secondary structure of the HAV peptide which regulates cadherin-cadherin interaction J. Biomol. Struct. Dyn. 1995, 13, 447-455 (Pubitemid 26013697)
118. Burden-Gulley, S. M.; Gates, T. J.; Craig, S. E. L.; Lou, S. F.; Oblander, S. A.; Howell, S.; Gupta, M.; Brady-Kalnay, S. M. Novel peptide mimetic small molecules of the HAV motif in N-cadherin inhibit N-cadherin-mediated neurite outgrowth and cell adhesion Peptides 2009, 30, 2380-2387
119. Burden-Gulley, S. M.; Gates, T. J.; Craig, S. E. L.; Gupta, M.; Brady-Kalnay, S. M. Stimulation of N-cadherin-dependent neurite outgrowth by small molecule peptide mimetic agonists of the N-cadherin HAV motif Peptides 2010, 31, 842-849
120. Kawasaki, M.; Maeda, T.; Hanasawa, K.; I., O.; T., T. Effect of His-Gly-Lys motif derived from domain 5 of high molecular weight kininogen on suppression of cancer metastasis both in vitro and in vivo J. Biol. Chem. 2003, 278, 49301-49307
121. Giebel, L. B.; Cass, R. T.; Milligan, D. L.; Young, D. C.; Arze, R.; Johnson, C. R. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities Biochemistry 1995, 34, 15430-15435
122. Skerra, A.; Schmidt, T. G. M. Use of the strep-tag and streptavidin for detection and purification of recombinant proteins Methods Enzymol. 2000, 326, 271-304
123. a of the peptide histidine is less than 3.0 J. Biol. Chem. 1997, 272, 13220-13228 (Pubitemid 27216749)
124. Katz, B. A. Streptavidin-binding and -dimerizing ligands discovered by phage display, topochemistry, and structure-based design Biomol. Eng. 1999, 16, 57-65 (Pubitemid 30184839)
125. Brzoska, T.; Luger, T. A.; Maaser, C.; Abels, C.; Bohm, M. Melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases Endocr. Rev. 2008, 29, 581-602
126. Cutuli, M.; Cristiani, S.; Lipton, J. M.; Catania, A. J. Antimicrobial effects of alpha-MSH peptides J. Leukocyte Biol. 2000, 67, 233-239
127. Komoriya, A.; Green, L. J.; Mervic, M.; Yamada, S. S.; Yamada, K. M.; Humphries, M. J. The minimal essential sequence for a major cell type-specific adhesion site (Cs1) within the alternatively spliced type-III connecting segment domain of fibronectin is leucine-aspartic acid-valine J. Biol. Chem. 1991, 266, 15075-15079 (Pubitemid 21907620)
128. 1. Inhibition of alpha-4-beta-1 function by RGD peptide homologs J. Biol. Chem. 1991, 266, 3579-3585 (Pubitemid 21909252)
129. Akiyama, S. K.; Olden, K.; Yamada, K. M. Fibronectin and integrins in invasion and metastasis Cancer Metastasis Rev. 1995, 14, 173-189
130. Doyle, P. M.; Harris, J. C.; Moody, C. M.; Sadler, P. J.; Sims, M.; Thornton, J. M.; Uppenbrink, J.; Viles, J. H. Solution structure of a biologically active cyclic LDV peptide analogue containing a type II′ beta-turn mimetic Int. J. Pept. Protein Res. 1996, 47, 427-436
131. Viles, J. H.; Mitchell, J. B. O.; Gough, S. L.; Doyle, P. M.; Harris, C. J.; Sadler, P. J.; Thornton, J. M. Multiple solution conformations of the integrin-binding cyclic pentapeptide cyclo(-Ser- d -Leu-Asp-Val-Pro-) analysis of the (phi,psi) space available to cyclic pentapeptides Eur. J. Biochem. 1996, 242, 352-362 (Pubitemid 26414242)
132. Jackson, D. Y.; Quan, C.; Artis, D. R.; Rawson, T.; Blackburn, B.; Struble, M.; Fitzgerald, G.; Chan, K.; Mullins, S.; Burnier, J. P.; Fairbrother, W. J.; Clark, K.; Berisini, M.; Chui, H.; Renz, M.; Jones, S.; Fong, S. Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents J. Med. Chem. 1997, 40, 3359-3368 (Pubitemid 27441328)
133. 1 in the third fibronectin type III repeat of tenascin-C J. Biol. Chem. 1998, 273, 11423-11428 (Pubitemid 28272033)
134. 1 that inhibit allergic airway responses J. Med. Chem. 1999, 42, 920-934 (Pubitemid 29136181)
135. Yang, G. X.; Hagmann, W. K. VLA-4 antagonists: potent inhibitors of lymphocyte migration Med. Res. Rev. 2003, 23, 369-392 (Pubitemid 36457540)
136. Chen, L.; Tilley, J.; Trilles, R. V.; Yun, W. Y.; Fry, D.; Cook, C.; Rowan, K.; Schwinge, V.; Campbell, R. N -Acyl- l -phenylalanine derivatives as potent VLA-4 antagonists that mimic a cyclic peptide conformation Bioorg. Med. Chem. Lett. 2002, 12, 137-140 (Pubitemid 34037952)
137. Hagmann, W. K. The discovery and potential of N-sulfonylated dipeptide VLA-4 antagonists Curr. Top. Med. Chem. 2004, 4, 1461-1471 (Pubitemid 39317602)
138. Hagmann, W. K.; Durette, P. L.; Lanza, T.; Kevin, N. J.; de Laszlo, S. E.; Kopka, H. E.; Young, D.; Magriotis, P. A.; Li, B.; Lin, L. S.; Yang, G.; Kamenecka, T.; Chang, L. L.; Wilson, J.; MacCoss, M.; Mills, S. G.; Van Riper, G.; McCauley, E.; Egger, L. A.; Kidambi, U.; Lyons, K.; Vincent, S.; Stearns, R.; Colletti, A.; Teffera, J.; Tong, S.; Fenyk-Melody, J.; Owens, K.; Levorse, D.; Kim, P.; Schmidt, J. A.; Mumford, R. A. The discovery of sulfonylated dipeptides as potent VLA-4 antagonists Bioorg. Med. Chem. Lett. 2001, 11, 2709-2713 (Pubitemid 32925300)
139. Tilley, J. W. Very late antigen-4 integrin antagonists Expert Opin. Ther. Pat. 2008, 18, 841-859
140. Pierschbacher, M. D.; Ruoslahti, E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule Nature 1984, 309, 30-33 (Pubitemid 14134132)
141. Ojima, I.; Chakravarty, S.; Dong, Q. Antithrombotic agents: from RGD to peptide mimetics Bioorg. Med. Chem. 1995, 3, 337-360
142. Wang, W.; Borchardt, R. T.; Wang, B. Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists Curr. Med. Chem. 2000, 7, 437-453 (Pubitemid 30396435)
143. 3 based on electron cryomicroscopy and X-ray crystallography Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 14059-14064 (Pubitemid 35257624)
144. 3 integrin J. Med. Chem. 2003, 46, 5316-5325
145. 3 in native platelets than in liposomes J. Am. Chem. Soc. 2005, 127, 916-919 (Pubitemid 40144290)
146. Xiao, T.; Takagi, J.; Coller, B. S.; Wang, J.-H.; Springer, T. A. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics Nature 2004, 432, 59-67 (Pubitemid 39490825)
147. Zablocki, J. A.; Miyano, M.; Garland, R. B.; Pireh, D.; Schretzman, L.; Rao, S. N.; Lindmark, R. J.; Panzerknodle, S. G.; Nicholson, N. S.; Taite, B. B.; Salyers, A. K.; King, L. W.; Campion, J. G.; Feigen, L. P. Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor J. Med. Chem. 1993, 36, 1811-1819 (Pubitemid 23203738)
148. Alig, L.; Edenhofer, A.; Hadvary, P.; Hurzeler, M.; Knopp, D.; Muller, M.; Steiner, B.; Trzeciak, A.; Weller, T. Low molecular weight, non-peptide fibrinogen receptor antagonists J. Med. Chem. 1992, 35, 4393-4407
149. Jones, C. R.; Ambros, R. J.; Rapold, H. J.; Steiner, B.; Weller, T.; van Heiningen, P.; Crijins, H. J. M. J.; Jonkman, J. H. G.; Hadvary, P. A novel non peptide GPIIb/IIIa antagonist in man Thromb. Haemostasis 1993, 69, 560
150. Scarborough, R. M.; Rose, J. W.; Hsu, M. A.; Phillips, D. R.; Fried, V. A.; Campbell, A. M.; Nannizzi, L.; Charo, I. F. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri J. Biol. Chem. 1991, 266, 9359-9362 (Pubitemid 21906663)
151. Scarborough, R. M.; Naughton, M. A.; Teng, W.; Rose, J. W.; Phillips, D. R.; Nannizzi, L.; Arfsten, A.; Campbell, A. M.; Charo, I. F. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa J. Biol. Chem. 1993, 268, 1066-1073 (Pubitemid 23019743)
152. Blum, J. E.; Handmaker, H. Small peptide radiopharmaceuticals in the imaging of acute thrombus Curr. Pharm. Des. 2002, 8, 1815-26
153. Haubner, R.; Wester, H. J. Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies Curr. Pharm. Des. 2004, 10, 1439-55 (Pubitemid 38559759)
154. Gould, S. J.; Keller, G.; Subramani, S. Identification of a peroxisomal targeting signal at the carboxy terminus of firefly luciferase J. Cell Biol. 1987, 105, 2923-2931 (Pubitemid 18043870)
155. Gould, S. J.; Keller, G.; Hosken, N.; Wilkinson, J.; Subramani, S. A conserved tripeptide sorts proteins to peroxisomes J. Cell Biol. 1989, 108, 1657-1664 (Pubitemid 19130498)
156. Gatto, G. J. J.; Geisbrecht, B. V.; Gould, S. J.; Berg, J. M. Peroxisomal targeting signal-1 recognition by the TPR domains of human PEX5 Nat. Struct. Biol. 2000, 7, 1091-1095
157. Brocard, C.; Hartig, A. Peroxisome targeting signal 1: Is it really a simple tripeptide? Biochim. Biophys. Acta, Mol. Cell Res. 2006, 1763, 1565-1573 (Pubitemid 44880463)
158. Lam, K. S.; Lebl, M.; Krchnak, V. The "one-bead-one-compound" combinatorial library method Chem. Rev. 1997, 97, 411-448
159. Boger, D. L.; Desharnais, J.; Capps, K. Solution-phase combinatorial libraries: modulating cellular signaling by targeting protein-protein or protein-DNA interactions Angew. Chem., Int. Ed. 2003, 42, 4138-4176 (Pubitemid 37168929)